Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes (Q51541588)

6 April 2018

title

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes (English)

1 reference

6 April 2018

1 reference

Pamela J Goodwin

0 references

Marguerite Ennis

1 reference

6 April 2018

Kathleen I Pritchard

1 reference

6 April 2018

Maureen E Trudeau

1 reference

6 April 2018

Jarley Koo

1 reference

6 April 2018

Warren Hartwick

1 reference

6 April 2018

Barry Hoffma

1 reference

6 April 2018

Nicky Hood

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 July 2002

1 reference

6 April 2018

Breast Cancer Research and Treatment

published in

1 reference

6 April 2018

volume

1 reference

6 April 2018

issue

1 reference

6 April 2018

page(s)

65-76

1 reference

6 April 2018

The insulin-like growth factors and breast cancer — revisited

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Leptin and insulin growth factor I in relation to breast cancer (Greece)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Serum insulin-like growth factor-I and breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Free insulin-like growth factor-I and breast cancer risk

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

IGF-independent regulation of breast cancer growth by IGF binding proteins

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Serum levels of insulin-like growth factor binding protein-3 in benign and malignant breast disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Correlation of Insulin-Like Growth Factor-Binding Protein-3 Messenger RNA With Protein Expression in Primary Breast Cancer Tissues: Detection of Higher Levels in Tumors With Poor Prognostic Features

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

A data-based approach to diet questionnaire design and testing

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Adjustment for total energy intake in epidemiologic studies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1016075709022

7 January 2021

Identifiers

DOI

10.1023/A:1016075709022

1 reference

6 April 2018

Dimensions Publication ID

1018174671

0 references

1 reference

6 April 2018